SHARE

Nasdaq-listed Natus Medical to be taken private following ArchiMed deal

Natus, the US provider of medical device solutions to treat brain disorders and neural pathways, has agreed to be acquired by a subsidiary of Archimed, a French investment firm specialising in the healthcare sector. The deal is worth nearly $1.2bn.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.